Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Acosta

Showing results (171-180 of 338) with videos related to

Pageof 34
Sort By:
CPT: Pharmacometrics & Systems Pharmacology|June 20, 2019
Maternal-Neonatal Raltegravir Population Pharmacokinetics Modeling: Implications for Initial Neonatal DosingJos Lommerse, Diana Clarke, Thomas Kerbusch, et al.
The Journal of Infectious Diseases|February 26, 2009
Associations between CYP2B6 polymorphisms and pharmacokinetics after a single dose of nevirapine or efavirenz in African americansDavid W Haas, Tebeb Gebretsadik, Gail Mayo, et al.
Plos Neglected Tropical Diseases|October 3, 2012
High prevalence of Schistosoma japonicum infection in Carabao from Samar Province, the Philippines: implications for transmission and controlCatherine A Gordon, Luz P Acosta, Darren J Gray, et al.
Annals of Hepatology|June 12, 2019
Mutations identified in a cohort of Mexican patients with lysosomal acid lipase deficiencyAlejandra Consuelo-Sánchez, Rodrigo Vázquez-Frias, Alejandra Reyes-De La Rosa, et al.
Journal of Clinical Pharmacology|January 7, 2011
Immune activation mediated change in alpha-1-acid glycoprotein: impact on total and free lopinavir plasma exposureIghovwerha Ofotokun, Jeffrey L Lennox, Molly E Eaton, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|October 27, 2004
Evaluation of the reproductive and developmental toxicity of the D-003, a mixture of long-chain fatty acids, in rats and rabbitsM D Rodríguez, J E González, C Alemán, et al.
The Pediatric Infectious Disease Journal|October 13, 2005
Efficacy, tolerability and pharmacokinetics of two nelfinavir-based regimens in human immunodeficiency virus-infected children and adolescents: pediatric AIDS clinical trials group protocol 403Jennifer R King, Sharon Nachman, Ram Yogev, et al.
Annals of Internal Medicine|November 17, 2005
Impact of efavirenz on neuropsychological performance and symptoms in HIV-infected individualsDavid B Clifford, Scott Evans, Yijun Yang, et al.
Pulmonary Pharmacology & Therapeutics|July 4, 2024
Differential distribution of ivacaftor and its metabolites in plasma and human airway epitheliaZhongyu Liu, Justin D Anderson, Natalie R Rose, et al.
AIDS (London, England)|April 3, 2004
Universal nevirapine upon presentation in labor to prevent mother-to-child HIV transmission in high prevalence settingsJeffrey S A Stringer, Moses Sinkala, Robert L Goldenberg, et al.
Pageof 34

Showing results (171-180 of 338) with videos related to

Sort By:
Pageof 34
CPT: Pharmacometrics & Systems Pharmacology|June 20, 2019
Maternal-Neonatal Raltegravir Population Pharmacokinetics Modeling: Implications for Initial Neonatal DosingJos Lommerse, Diana Clarke, Thomas Kerbusch, et al.
The Journal of Infectious Diseases|February 26, 2009
Associations between CYP2B6 polymorphisms and pharmacokinetics after a single dose of nevirapine or efavirenz in African americansDavid W Haas, Tebeb Gebretsadik, Gail Mayo, et al.
Plos Neglected Tropical Diseases|October 3, 2012
High prevalence of Schistosoma japonicum infection in Carabao from Samar Province, the Philippines: implications for transmission and controlCatherine A Gordon, Luz P Acosta, Darren J Gray, et al.
Annals of Hepatology|June 12, 2019
Mutations identified in a cohort of Mexican patients with lysosomal acid lipase deficiencyAlejandra Consuelo-Sánchez, Rodrigo Vázquez-Frias, Alejandra Reyes-De La Rosa, et al.
Journal of Clinical Pharmacology|January 7, 2011
Immune activation mediated change in alpha-1-acid glycoprotein: impact on total and free lopinavir plasma exposureIghovwerha Ofotokun, Jeffrey L Lennox, Molly E Eaton, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|October 27, 2004
Evaluation of the reproductive and developmental toxicity of the D-003, a mixture of long-chain fatty acids, in rats and rabbitsM D Rodríguez, J E González, C Alemán, et al.
The Pediatric Infectious Disease Journal|October 13, 2005
Efficacy, tolerability and pharmacokinetics of two nelfinavir-based regimens in human immunodeficiency virus-infected children and adolescents: pediatric AIDS clinical trials group protocol 403Jennifer R King, Sharon Nachman, Ram Yogev, et al.
Annals of Internal Medicine|November 17, 2005
Impact of efavirenz on neuropsychological performance and symptoms in HIV-infected individualsDavid B Clifford, Scott Evans, Yijun Yang, et al.
Pulmonary Pharmacology & Therapeutics|July 4, 2024
Differential distribution of ivacaftor and its metabolites in plasma and human airway epitheliaZhongyu Liu, Justin D Anderson, Natalie R Rose, et al.
AIDS (London, England)|April 3, 2004
Universal nevirapine upon presentation in labor to prevent mother-to-child HIV transmission in high prevalence settingsJeffrey S A Stringer, Moses Sinkala, Robert L Goldenberg, et al.
Pageof 34